Letters to the Editor
Managing Inflammatory Bowel Disease in a Broken Health Care System
Brad Pasternak MD,
Corresponding Author
Brad Pasternak MD
Phoenix Children’s Hospital, University of Arizona College of Medicine, Phoenix, AZ
Address correspondence and reprint requests to Brad Pasternak, MD, Phoenix Children’s Hospital, University of Arizona College of Medicine, Phoenix, AZ 85016 (e-mail:
[email protected]).
Search for more papers by this author
Brad Pasternak MD,
Corresponding Author
Brad Pasternak MD
Phoenix Children’s Hospital, University of Arizona College of Medicine, Phoenix, AZ
Address correspondence and reprint requests to Brad Pasternak, MD, Phoenix Children’s Hospital, University of Arizona College of Medicine, Phoenix, AZ 85016 (e-mail:
[email protected]).
Search for more papers by this author
First published: 21 April 2023
No abstract is available for this article.
REFERENCES
- 1.Choi DK, Cohen NA, Choden T, et al. Delays in therapy associated with current prior authorization process for the treatment of inflammatory bowel disease. Inflamm Bowel Dis 2023:izad012. doi:10. 1093/ibd/izad012.
- 2.Constant B, de Zoeten E, Stahl MG, et al. Delays related to prior authorization in inflammatory bowel disease. Pediatrics 2022; 149: e202105201. doi:10.1542/peds.2021-052501.
- 3.Kahn S, Bousvaros A. Denials, dilly-dallying, and despair: navigating the insurance labyrinth to obtain medically necessary medications for pediatric inflammatory bowel disease patients. J Pediatr Gastroenterol Nutr 2022; 75: 418–22.
- 4. AGA supports reducing prior authorization burdens that delay patient access to care. 2023. www.gastro.org. Available at: https://gastro.org/top-issues/aga-supports-reducing-prior-authorization-burdens-that-delay-patient-access-to-care/. Retrieved March 8, 2023.
